CervoMed Inc. (CRVO)

CervoMed Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	8.24	9	7.79	4.09	37.31
Short-Term Investments	12.63	29.92	-	-	-
Cash & Short-Term Investments	20.86	38.92	7.79	4.09	37.31
Cash Growth	-46.39%	399.46%	90.37%	-89.03%	101.53%
Other Receivables	0.43	2.25	0.92	-	-
Total Trade Receivables	0.43	2.25	0.92	-	-
Other Current Assets	1.59	1.91	1.26	0.06	0.51
Total Current Assets	22.88	43.08	9.96	4.16	37.82
Other Long-Term Assets	-	-	0.01	-	0.02
Total Assets	22.88	43.08	9.97	4.16	37.84
Accounts Payable	1.45	1.51	0.66	0.1	0.95
Accrued Expenses	3.2	2.37	1.93	0.64	1.98
Short-Term Debt	-	-	-	12.41	-
Total Current Liabilities	4.66	3.88	2.6	13.16	2.93
Total Liabilities	9.31	7.76	2.6	13.16	2.93
Preferred Stock	-	-	-	48.57	-
Common Stock	0.01	0.01	0.01	0	0
Additional Paid-in Capital	115.91	109.87	61.81	18.98	164.91
Accumulated Other Comprehensive Income	0.01	0.06	-	-	-
Retained Earnings	-97.7	-70.73	-54.44	-52.27	-130.01
Shareholders' Equity	18.22	39.2	7.38	-33.29	34.91
Total Liabilities & Equity	22.88	43.08	9.97	4.16	37.84
Total Debt	0	0	0	12.41	0
Net Cash (Debt)	20.86	38.92	7.79	-8.32	37.31
Net Cash Growth	-46.39%	399.46%	-	-	103.16%
Net Cash Per Share	2.31	4.82	2.93	-16.06	28.75
Book Value	18.22	39.2	7.38	-33.29	34.91
Book Value Per Share	2.02	4.86	2.77	-64.24	26.90
Tangible Book Value	18.22	39.2	7.38	-33.29	34.91
Tangible Book Value Per Share	2.02	4.86	2.77	-64.24	26.90

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q